Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector

Project Information

GENEGRAFT

Grant agreement ID: 261392

Project closed

Start date 1 March 2011

End date 31 December 2017

Funded under

• Specific Programme "Cooperation": Health

Total cost

€ 6 584 623,18

EU contribution

€ 4 961 654,00

Coordinated by

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .